Helping heart failure patients stick with their medication
Part of Heart & circulation clinical trials.
This study tests if a pharmacist-led education program, using a dashboard, can help people with heart failure take their sacubitril/valsartan medicine as prescribed. If you have heart failure with reduced ejection fraction (HFrEF) and are already on this medication, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years old or older.
- You have heart failure with reduced ejection fraction (HFrEF), meaning your heart's pumping ability is 40% or less.
- You are currently taking the medication sacubitril/valsartan (sometimes called Entresto).
- You are being treated at the cardiology department or ward at National Taiwan University Hospital.
- You have a doctor's referral from National Taiwan University Hospital.
- You can attend three follow-up visits (at 3, 6, and 12 months) and complete questionnaires in person.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether family-focused coaching and easy-to-read materials can improve heart failure medication adherence. It also uses an electronic pillbox to track how consistently you take your meds, with your care partner involved.
This trial tests a tool that helps you and your doctor talk about heart failure medications during your first clinic visit. It's designed for people with a specific type of heart failure (reduced ejection fraction) to make treatment decisions easier.
This study tests whether remote check-ins via phone or video can help safely increase heart failure medications to target doses. You'll use a device to share weight, blood pressure, and heart rate with your doctor, who will adjust your medicines based on how you're doing.
This study tests whether using a visual tool (like a chart or app) helps people with heart failure stick to their medications and feel better. It's for adults whose heart pumps weakly (ejection fraction 40% or less) and are ready to start or adjust guideline-recommended heart failure drugs.
This trial tests a program to help people who have had a heart attack, stroke, or other blood vessel disease take their heart medications every day. It is for patients who sometimes miss their pills and want better support.
This study looks at whether patients with severe heart failure follow their prescribed medications as recommended by treatment guidelines. The researchers want to understand what helps or prevents patients from taking their medicines correctly, which could improve their heart function and symptoms.
Hear when a new Sacubitril/Valsartan trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.